Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement In Response To Recent Accumulations Of Its Common Stock

Benzinga · 4d ago

The Rights Agreement will expire on March 11, 2026, or earlier, as provided in the Rights Agreement.

Under the Rights Agreement, the rights generally become exercisable if a person or a group of persons acquires beneficial ownership of 10% (or 20% in the case of certain investors filing on Schedule 13G) or more of the outstanding shares of Pliant common stock in a transaction not approved by the Board.